Bladder Cancer Genomics Data Access Committee – Erlangen–Bonn Collaboration

Dr Maria D M Muniz Moreno
mariadelmar.munizmoreno@uk-erlangen.de

Request Access

Dataset ID	Description	Technology	Samples
EGAD50000002920	This controlled-access dataset comprises raw single-end FASTQ files generated from 137 bladder cancer tumor samples collected from 112 patients using the Lexogen QuantSeq 3′ mRNA-Seq protocol on the Illumina NovaSeq 6000 platform. Access is governed by the Bladder Cancer Genomics Data Access Committee (DAC) and the associated controlled-access policy.	Illumina NovaSeq 6000	137
EGAD50000002921	This controlled-access dataset contains processed gene-level expression counts generated from 137 bladder cancer tumor samples collected from 112 patients. Gene expression quantification was performed using the nf-core/rnaseq workflow with Salmon, and transcript-level abundance estimates were aggregated to gene-level counts. Access is governed by the Bladder Cancer Genomics Data Access Committee (DAC) and the associated controlled-access policy.	Illumina NovaSeq 6000	137
EGAD50000002922	This controlled-access dataset contains curated clinical metadata associated with 137 bladder cancer tumor samples obtained from 112 patients. Variables include patient demographics, clinician-assigned phenotype, overall survival (OS), progression-free survival (PFS), and corresponding event status variables. Access is governed by the Bladder Cancer Genomics Data Access Committee (DAC) and the associated controlled-access policy.	Illumina NovaSeq 6000	137